Now Available: United Kingdom Pharmaceuticals & Healthcare Report Q1 2015
The pharmaceutical and healthcare markets of the United Kingdom are driven by government spending in the form of the National Health System (NHS), which accounts for over 80% of total healthcare spending. With a higher prevalence of non-communicable diseases, coupled with an ageing population, the increased demand for healthcare may lead to the enforcement of cost - containment strategies and movement away from expensive treatment options.
View full press release